Pathophysiology of chorea and bradykinesia in Huntington's disease
- 1 May 1999
- journal article
- review article
- Published by Wiley in Movement Disorders
- Vol. 14 (3) , 398-403
- https://doi.org/10.1002/1531-8257(199905)14:3<398::aid-mds1003>3.0.co;2-f
Abstract
This article reviews the neurophysiological abnormalities described in Huntington's disease. Among the typical features of choreic movements are variable and random patterns of electromyographic (EMG) activity, including cocontraction of agonist and antagonist muscles. Studies of premotor potentials show that choreic movements are not preceded by a Bereitschaftspotential, therefore demonstrating that choreic movement is involuntary. Early cortical median‐nerve somatosensory‐evoked potentials have reduced amplitudes and the reduction correlates with reduced glucose consumption in the caudate nucleus. Long‐latency stretch reflexes evoked in the small hand muscles are depressed. These findings may reflect failed thalamocortical relay of sensory information. In Huntington's disease, the R2 response of the blink reflex has prolonged latencies, diminished amplitudes, and greater habituation than normal. These abnormalities correlate with the severity of chorea in the face. Patients with Huntington's disease perform simple voluntary movements more slowly than normal subjects and with an abnormal triphasic EMG pattern. Bradykinesia is also present during their performance of simultaneous and sequential movements. Eye movements show abnormalities similar to those seen in arm movements. In Huntington's disease, arm movement execution is associated with reduced PET activation of cortical frontal areas. Studies using transcranial magnetic stimulation show that patients with Huntington's disease have normal corticospinal conduction but some patients have a prolonged cortical silent period. Bradykinesia results from degeneration of the basal ganglia output to the supplementary motor areas concerned with the initiation and maintenance of sequential movements. The coexisting hyperkinetic and hypokinetic movement disorders in patients with Huntington's disease probably reflect the involvement of direct and indirect pathways in the basal ganglia–thalamus–cortical motor circuit.Keywords
This publication has 64 references indexed in Scilit:
- Early Loss of Neostriatal Striosome Neurons in Huntingtonʼs DiseaseJournal of Neuropathology and Experimental Neurology, 1995
- Dopamine D1 receptor number — a sensitive PET marker for early brain degeneration in Huntington's diseaseArchiv Fur Psychiatrie Und Nervenkrankheiten, 1994
- Neurochemical substrates of rigidity and chorea in Huntington's diseaseBrain, 1993
- Striatal and nigral neuron subpopulations in rigid Huntington's disease: Implications for the functional anatomy of chorea and rigidity‐akinesiaAnnals of Neurology, 1990
- THE ROLE OF THE SUBTHALAMIC NUCLEUS IN EXPERIMENTAL CHOREABrain, 1989
- The functional anatomy of basal ganglia disordersTrends in Neurosciences, 1989
- CHOREA AND MYOCLONUS IN THE MONKEY INDUCED BY GAMMA-AMINOBUTYRIC ACID ANTAGONISM IN THE LENTIFORM COMPLEXBrain, 1988
- Differential loss of striatal projection neurons in Huntington disease.Proceedings of the National Academy of Sciences, 1988
- On ChoreaClinical Neuropharmacology, 1986
- Experimental choreoathetosis produced by injection of a gamma-aminobutyric acid antagonist into the lentiform nucleus in the monkeyNeuroscience Letters, 1984